Long-term remission in multiple myeloma—a blood cancer once considered incurable—is finally becoming a reality. A single ...

Cevostamab showed a 93% MRD-negative complete response rate at 1 year post CAR T-cell therapy in heavily pretreated multiple myeloma patients. Cevostamab delivered feasible and well-tolerated ...

Although multiple myeloma is often considered incurable, the development of highly effective new therapies is creating a real possibility of a cure for some patients. Current 4-drug upfront regimens, ...

Belantamab mafodotin (Blenrep), pomalidomide (Pomalyst), and dexamethasone (BPd) was well tolerated and led to deep responses in patients with high-risk multiple myeloma.

As September concludes, the landscape of hematologic oncology continues to evolve, spanning the full spectrum of blood cancer ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

A growing list of contemporary phase 3 trials have shown that more drugs (quadruplet therapies) are superior to less drugs ...

At a median follow-up of 39.4 months, results from the second interim analysis showed a sustained and significant OS benefit with BVd compared to DVd.

Bristol-Myers Squibb Company (NYSE:BMY) ranks among the top picks for a retirement portfolio. Bristol-Myers Squibb Company (NYSE:BMY) reported on September 23 that its Phase 3 EXCALIBER-RRMM trial ...

The main implication of our study is support for incorporating quadruplet regimens into new guidelines for the management of transplant-ineligible patients newly diagnosed multiple myeloma,” the ...

STEVENS COUNTY, Wash. — The State Fire Marshal's Office approved state mobilization for two wildfires burning in Stevens County near Northport on Sunday. According to Stevens County Emergency ...